BioPharma Resources

Company · PFE

Pfizer

Includes drugs filed under related and acquired sponsor names. Trials are searched under: Pfizer; Seagen Inc..

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

423

168 still marketed

Novel approvals

130

Approvals since 2021

62

Originals and new uses

Phase 3 trials

815

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Talzenna new use Priority reviewOct 26, 2026
  • Talzenna new use Priority reviewOct 26, 2026
  • Tukysa new use OrphanOct 7, 2026
  • Ibrance new use Breakthrough therapyJun 24, 2026
  • Ibrance new use Breakthrough therapyJun 24, 2026
  • Hympavzi new use Priority reviewOrphanJun 5, 2026
  • Xeljanz new use Mar 6, 2026
  • Xeljanz Xr new use Mar 6, 2026
  • Xeljanz new use Oct 16, 2025
  • Ibrance new use Sep 16, 2025

Drugs in development (38)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • BerobenatidePF-08653944, MET097Phase 319 trials

    Pfizer · Obesity, Overweight and/or Obesity, Overweight

  • GiredestrantRO7197597, GDC-9545Phase 316 trials

    Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer

  • PF-08634404SSGJ-707Phase 312 trials

    Pfizer · Non-Small Cell Lung Cancer, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung (NSCLC)

  • AtirmociclibPF-07220060Phase 39 trials

    Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • RSVpreFRESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, PF-06928316Phase 38 trials

    Pfizer · Respiratory Syncytial Virus (RSV), Lower Respiratory Tract Illness, Adult

  • PG4Phase 35 trials

    Pfizer · Pneumococcal Disease

  • DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization

  • VLA15PF-07307405Phase 34 trials

    Pfizer · Lyme Disease, Lyme Borreliosis

  • CasdatifanAB521Phase 33 trials

    Arcus Biosciences, Inc. · Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC)

  • Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials

    Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate

  • MevrometostatPF-06821497Phase 33 trials

    Pfizer · Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer

  • RSVpreF VaccinePhase 33 trials

    Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)

  • Sigvotatug VedotinSGN-B6A, PF-08046047Phase 33 trials

    Pfizer · Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

  • C.difficile vaccinepreviously studiedPhase 32 trials

    Pfizer · Clostridoides Difficile Associated Disease

  • CMP 001VidutolimodPhase 32 trials

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • ibuzatrelvirPF-07817883Phase 32 trials

    Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection

  • PF-07248144Phase 32 trials

    Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • PF-08046054SGN-PDL1VPhase 32 trials

    Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma

  • su vaccineRZVPhase 32 trials

    GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)

  • PF-06823859Phase 31 trial

    Pfizer · Myositis

  • PF-06838435fidanacogene elaparvovecPhase 31 trial

    Pfizer · Hemophilia B

  • PF04518600Phase 31 trial

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • ponsegromabPhase 31 trial

    Pfizer · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma

  • Prevenar 20Phase 31 trial

    Pfizer · Healthy

Recruiting Phase 3 trials

Largest first.

Marketed drugs (168)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.